PharmaCyte Biotech (PMCB) Payables (2011 - 2026)
PharmaCyte Biotech's Payables came in at $423,026 for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 9.1% from $465,209 a year earlier but up 39.3% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Payables (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Payables was $303,593, down 24.0% from FY2025.
- Payables carries a five-year compound annual growth rate of 12.0% (FY2021 to FY2026).
- Going back by fiscal year, Payables was $399,204 in FY2025 (-94.3%), $7.03 million in FY2024, $128,281 in FY2023 (-37.5%) and $205,361 in FY2022 (+19.2%).
- The five-year range for quarterly Payables is $92,861 (fiscal Q3 2022) to $7.03 million (fiscal Q4 2024).
- Year-over-year, Payables increased in 1 of the last eight quarters, with an average decline of 29.6%.
- The fastest year-over-year change in Payables over five years came in fiscal Q1 2025 (growth of 554.0%), and the weakest in fiscal Q4 2025 (a decline of 94.3%).
- Business Quant data shows PMCB's Payables at $303,593 (Q4 2026), $1.23 million (Q3 2026) and $1.06 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | 423,026.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 423,026.00 |
| Apr 30, 2026 | 303,593.00 |
| Jan 31, 2026 | 1.23 Mn |
| Oct 31, 2025 | 1.06 Mn |
| Jul 31, 2025 | 465,209.00 |
| Apr 30, 2025 | 399,204.00 |
| Jan 31, 2025 | 484,948.00 |
| Oct 31, 2024 | 4.07 Mn |
| Jul 31, 2024 | 6.79 Mn |
| Apr 30, 2024 | 7.03 Mn |
| Jan 31, 2024 | 6.76 Mn |
| Oct 31, 2023 | 4.22 Mn |
| Jul 31, 2023 | 1.04 Mn |
| Apr 30, 2023 | 128,281.00 |
| Jan 31, 2023 | 445,935.00 |
| Oct 31, 2022 | 861,276.00 |
| Jul 31, 2022 | 559,026.00 |
| Apr 30, 2022 | 205,361.00 |
| Jan 31, 2022 | 92,861.00 |
| Oct 31, 2021 | 157,039.00 |
API Access
PharmaCyte Biotech Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();